"Over the past 25 years, the UK has introduced several programmes to evaluate and improve the quality of care received by heart failure patients. However, little was known about patients' journey of care across primary and secondary care services. This is a critical component of chronic disease management, so we set about addressing these knowledge gaps in order to provide evidence-based recommendations to strengthen health systems," said Dr Nathalie Conrad who led the research using participants in the Clinical Practice Research Datalink.
The research team found that, overall, patients were more likely to be diagnosed with heart failure in hospital rather than by their general practitioner; received insufficient follow-up after hospitalisation; and doses of key medicines prescribed to patients were far below those recommended by clinical management guidelines, even a year after diagnosis. Critically, only 17% of patients diagnosed with heart failure in hospital had their diagnosis recorded by their general practitioner in the following 12 months.
Women and older patients were particularly disadvantaged across all these care dimensions. In particular, women were 13% less likely than men of the same age to receive a prescription for the two most important drugs in heart failure management within three months of diagnosis. Women were also 9% less likely than men of the same age and socioeconomic status to be first diagnosed with heart failure in a general practice.
"Heart failure is a severe condition and early diagnosis is crucial for doctors to rapidly initiate life-saving medications. Our findings suggest out-of-hospital screening for early signs of heart failure and follow-up are sub-optimal, and women and older patients are particularly vulnerable to these shortcomings in current heart failure care," said Conrad.
"Health systems need to adopt a broader perspective of service design and recognise the patient journey as a care continuum to improve care quality, adhere to recommended treatment guidelines and provide more equitable access for all those at risk of, or living with, heart failure. Particular attention needs to be given to women and older patients to ensure they receive the treatment they need within the recommended timeframe," added Conrad.
Heart failure affects about 2% of the population in high-income countries, with mortality rates comparable to the most severe cancers . Effective treatments exist but involve a complex process of investigation and step-wise initiation of medication and adjustment - care programmes that are often challenging to implement consistently.
The study was funded by the British Heart Foundation, the Oxford Martin School at the University of Oxford, and by the NIHR Oxford Biomedical Research Centre.
The paper is published in PLOS Medicine, and will be available from this link: http://journals.
 Global Public Health Burden of Heart Failure
Notes for editors
The George Institute for Global Health, University of Oxford
Tel: 07918 553680
About The George Institute for Global Health
The George Institute for Global Health conducts clinical, population and health system research aimed at changing health practice and policy worldwide. The Institute has a global network of medical and health experts working together to address the leading causes of death and disability. Established in Australia and affiliated with UNSW Sydney, the Institute today also has offices in China, India and the United Kingdom. The George Institute UK was established in 2010 in partnership with the University of Oxford. Facebook at thegeorgeinstitute Twitter @GeorgeInstUK Web georgeinstitute.org.uk